Study of inhibition of CYP2A6 by some drugs derived from quinoline

No abstract is available for this paper.

• Publication year

  2003

• Venue

  The Journal of pharmacy and pharmacology

• Publication date

  2003-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1211/0022357022278PMID 14738594
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CYP2A6/2A7 and CYP2E1 expression in human oesophageal mucosa: regional and inter-individual variation in expression and relevance to nitrosamine metabolism.

  2002cited by this paper
• The Influence of Quinolines on Coumarin 7- Hydroxylation in Bovine Liver Microsomes and Human CYP2A6

  2002cited by this paper
• Study of in vitro glucuronidation of hydroxyquinolines with bovine liver microsomes

  2002cited by this paper
• Homology modelling of human CYP2 family enzymes based on the CYP2C5 crystal structure

  2002cited by this paper
• Molecular Orbital Calculations and Nicotine Metabolism: A Rationale for Experimentally Observed Metabolite Ratios

  2002cited by this paper
• Molecular modeling of human cytochrome P450–substrate interactions

  2002cited by this paper
• CYP2A6 activity determined by caffeine phenotyping: association with colorectal cancer risk.

  2002cited by this paper
• A study of the expression of the xenobiotic-metabolising cytochrome P450 proteins and of testosterone metabolism in bovine liver.

  2001cited by this paper
• Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.

  2000cited by this paper
• Pronounced differences in inhibition potency of lactone and non-lactone compounds for mouse and human coumarin 7-hydroxylases (CYP2A5 and CYP2A6).

  2000cited by this paper
• Anti-mutagenic structural modification by fluorine-substitution in highly mutagenic 4-methylquinoline derivatives.

  2000cited by this paper
• CYP2A6 gene deletion reduces susceptibility to lung cancer.

  1999cited by this paper
• Induced expression of CYP2A5 in inflamed trematode-infested mouse liver.

  1999cited by this paper
• Biotransformation of coumarin by rodent and human cytochromes P-450: metabolic basis of tissue-selective toxicity in olfactory mucosa of rats and mice.

  1999cited by this paper
• Cloning and Characterization of Syrian Hamster Testosterone 7α-Hydroxylase, CYP2A9

  1998cited by this paper
• Cloning and characterization of Syrian hamster testosterone 7 alpha-hydroxylase, CYP2A9.

  1998cited by this paper
• The P450 catalytic cycle and oxygenation mechanism.

  1998cited by this paper
• Inhibition of coumarin 7-hydroxylase activity in human liver microsomes.

  1997cited by this paper
• Expression of CYP2A genes in rodent and human nasal mucosa.

  1996cited by this paper
• Cytochrome P450 species involved in the metabolism of quinoline.

  1996cited by this paper
• Isolation and heterologous expression of cloned cDNAs for two rabbit nasal microsomal proteins, CYP2A10 and CYP2A11, that are related to nasal microsomal cytochrome P450 form a.

  1993cited by this paper
• A tobacco smoke-derived nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P4502D6.

  1991cited by this paper
• Identification and biochemical analysis of novel olfactory-specific cytochrome P-450IIA and UDP-glucuronosyl transferase.

  1990influential reference
• Cloning and characterization of two major 3-methylcholanthrene inducible hamster liver cytochrome P450s.

  1990cited by this paper
• The structure and characterization of type I P-450(15) alpha gene as major steroid 15 alpha-hydroxylase and its comparison with type II P-450(15) alpha gene.

  1989cited by this paper
• Purification and properties of bovine liver seryl-tRNA synthetase.

  1984cited by this paper
• THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE.

  1964cited by this paper

• Artesunate monotherapy versus artesunate plus quinine combination therapy for treatment of imported severe malaria: a TropNet retrospective cohort study

  2022cites this paper
• Odorant metabolizing enzymes in the peripheral olfactory process

  2016cites this paper
• Development and validation of a GC-MS method for nicotine detection in Calliphora vomitoria (L.) (Diptera: Calliphoridae).

  2016cites this paper
• Odorant Metabolism Catalyzed by Olfactory Mucosal Enzymes Influences Peripheral Olfactory Responses in Rats

  2013cites this paper
• Synthesis, crystal, computational study and in vitro anti-tuberculosis activity of N -(furan-2-yl-methyl)- N -(phenyl(quinolin-3-yl)methyl) acetamide derivatives

  2011cites this paper
• Toxicity of Xanthene Food Dyes by Inhibition of Human Drug-Metabolizing Enzymes in a Noncompetitive Manner

  2009cites this paper
• Toxicity of Xanthene Food Dyes by Inhibition of Human Drug-Metabolizing Enzymes in a Noncompetitive Manner

  2009cites this paper
• Inhibition of Human CYP3A4, UGT1A6, and P-glycoprotein with Halogenated Xanthene Food Dyes and Prevention by Superoxide Dismutase

  2008cites this paper
• In vitro activation of valproate glucuronidation by carbapenem antibiotics

  2007cites this paper
• New considerations regarding the risk assessment on Tartrazine An update toxicological assessment, intolerance reactions and maximum theoretical daily intake in France.

  2007cites this paper
• [Cytochrome P-450 and the response to antimalarial drugs].

  2006cites this paper
• Inhibition Mechanism of UDP-Glucuronosyltransferase 1A6 by Xanthene Food Dyes

  2006cites this paper
• El citocromo P-450 y la respuesta terapéutica a los antimaláricos

  2006cites this paper
• Influence of Synthetic and Natural Food Dyes on Activities of CYP2A6, UGT1A6, and UGT2B7

  2005cites this paper
• High-throughput screening of inhibitory potential of nine cytochrome P450 enzymes in vitro using liquid chromatography/tandem mass spectrometry.

  2005cites this paper
• Autoantibodies Against CYP2D6 and Other Drug-Metabolizing Enzymes in Autoimmune Hepatitis Type 2

  2005cites this paper
• New Horizon of MDR1 (P-glycoprotein) Study

  2005cites this paper
• High Levels of Autoantibodies against Drug-metabolizing Enzymes in SLA/LP-positive AIH-1 Sera

  2004cites this paper